Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
Phase II study assessing the effect of carfilzomib treatment on early free light chain kinetics in myeloma patients with renal impairmen